13-110306972-T-A

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_001845.6(COL4A1):​c.56A>T​(p.His19Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,475,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H19P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000030 ( 0 hom. )

Consequence

COL4A1
NM_001845.6 missense

Scores

2
1
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.847

Publications

0 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
COL4A2 Gene-Disease associations (from GenCC):
  • porencephaly 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • COL4A1 or COL4A2-related cerebral small vessel disease
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.28639293).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001845.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
NM_001845.6
MANE Select
c.56A>Tp.His19Leu
missense
Exon 1 of 52NP_001836.3P02462-1
COL4A1
NM_001303110.2
c.56A>Tp.His19Leu
missense
Exon 1 of 25NP_001290039.1P02462-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
ENST00000375820.10
TSL:1 MANE Select
c.56A>Tp.His19Leu
missense
Exon 1 of 52ENSP00000364979.4P02462-1
COL4A1
ENST00000543140.6
TSL:1
c.56A>Tp.His19Leu
missense
Exon 1 of 25ENSP00000443348.1P02462-2
COL4A1
ENST00000650424.2
c.56A>Tp.His19Leu
missense
Exon 1 of 52ENSP00000497477.2A0A3B3ISV3

Frequencies

GnomAD3 genomes
AF:
0.0000461
AC:
7
AN:
151956
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000237
AC:
2
AN:
84556
AF XY:
0.0000209
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000302
AC:
4
AN:
1323664
Hom.:
0
Cov.:
30
AF XY:
0.00000307
AC XY:
2
AN XY:
652128
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26932
American (AMR)
AF:
0.000105
AC:
3
AN:
28498
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23416
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29304
South Asian (SAS)
AF:
0.0000137
AC:
1
AN:
72968
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32814
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3998
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1050754
Other (OTH)
AF:
0.00
AC:
0
AN:
54980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.588
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152064
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41480
American (AMR)
AF:
0.000392
AC:
6
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5116
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67964
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Inborn genetic diseases (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
20
DANN
Benign
0.89
DEOGEN2
Benign
0.16
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.38
T
M_CAP
Pathogenic
0.94
D
MetaRNN
Benign
0.29
T
MetaSVM
Benign
-0.47
T
MutationAssessor
Benign
0.34
N
PhyloP100
0.85
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
0.83
N
REVEL
Uncertain
0.46
Sift
Benign
0.66
T
Sift4G
Benign
0.66
T
Polyphen
0.44
B
Vest4
0.25
MutPred
0.40
Gain of helix (P = 0.0199)
MVP
0.68
MPC
0.48
ClinPred
0.12
T
GERP RS
3.3
PromoterAI
0.020
Neutral
Varity_R
0.23
gMVP
0.47
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1456821193; hg19: chr13-110959319; API